MedTrace Logo

Scale-up the Introduction of Simulation Into Four New Health Professional Training Institutions in East and West Africa

NCT04872972 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2021-05-05

No results posted yet for this study

Summary

Simulation based learning practice is limited in Sub-Saharan Africa. Experiences gained from our prior implementation in Phase I of this program show that simulation is feasible and significantly contributes to learning. However, the growth and sustainability of simulation methodologies in health training and service delivery institutions is subject to variability and institution specific factors. These factors may include but are not limited to ease of adoption of new technologies, human resources, space and institutional culture. These factors are likely to vary widely in Sub-Saharan Africa across countries and institutions.

It's not known how institutional factors will influence the introduction, adoption and sustainability of simulation methodologies in East and West African health training and service delivery institutions. We have partnered with four institutions in East and West Africa (in Uganda, Tanzania, and Nigeria) to learn about the process of introduction and scaling of simulation based learning in new frontiers.

Conditions

  • Simulation-based Learning

Interventions

OTHER

Simulation based learning

Faculty development courses on simulation based learning

Sponsors & Collaborators

  • University of Calgary

    collaborator OTHER

  • The ELMA Foundation

    collaborator OTHER

  • Alberta Children's Hospital Research Institute

    collaborator OTHER

  • Laerdal Foundation

    collaborator OTHER

  • Mbarara University of Science and Technology

    lead OTHER

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-06-01
Primary Completion
2021-12-30
Completion
2022-12-30

Countries

  • Uganda

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04872972 on ClinicalTrials.gov